Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus

Clinical Science

Volumn 126, Issue 2, 2014, Pages 175-181

  Shiu, Sammy W M ^a   Xiao, Su Mei ^a   Wong, Ying ^a   Chow, Wing Sun ^a   Lam, Karen S L ^a   Tan, Kathryn C B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carbamylation; Cyanate; Lipoprotein; Myeloperoxidase; Uraemia

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; MYELOPEROXIDASE; ROSIGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL; UREA;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BODY MASS; CARBAMOYLATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PEROXIDASE; THIAZOLIDINEDIONES;

EID: 84885068902     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130369     Document Type: Article

References (24)

1. Itabe, H. (2009) Oxidative modification of LDL: its pathological role in atherosclerosis. Clin. Rev. Allergy Immunol. 37, 4-11
2. Lam, M. C., Tan, K. C. and Lam, K. S. (2004) Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis 177, 313-320
3. Basnakian, A. G., Shah, S. V., Ok, E., Altunel, E. and Apostolov, E. O. (2010) Carbamylated LDL. Adv. Clin. Chem. 51, 25-52
4. Apostolov, E. O., Ray, D., Savenka, A. V., Shah, S. V. and Basnakian, A. G. (2010) Chronic uremia stimulates LDL carbamylation and atherosclerosis. J. Am. Soc. Nephrol. 21, 1852-1857
5. Apostolov, E. O., Shah, S. V., Ok, E. and Basnakian, A. G. (2005) Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin. Chem. 51, 719-728
6. Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O., Hörkkö, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A. and Hazen, S. L. (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176-1184
7. Holzer, M., Zangge, K., El-Gmamal, D., Binder, V., Curcic, S., Konya, V., Schuligoi, R., Heinemann, A. and Marsche, G. (2012) Meyloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thoicyanate and urea: novel pathways generating dysfunctional high-density lipoproteins. Antioxid. Redox Signaling 17, 1043-1052
8. Klebanoff, S. J. (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93, 480-489
9. Karakas, M. and Koenig, W. (2012) Myeloperoxidase production by macrophage and risk of atherosclerosis. Curr. Atheroscler. Rep. 14, 277-283
10. Meuwese, M. C., Stroes, E. S., Hazen, S. L., van Miert, J. N., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J., Khaw, K. T. and Boekholdt, S. M. (2007) Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J. Am. Coll. Cardiol. 50, 159-165
11. Wiersma, J. J., Meuwese, M. C., van Miert, J. N., Kastelein, A., Tijssen, J. G., Piek, J. J. and Trip, M. D. (2008) Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med. Sci. Monit. 14, CR406-CR410
12. Tan, K. C., Chow, W. S., Tso, A. W., Xu, A., Tse, H. F., Hoo, R. L., Betteridge, D. J. and Lam, K. S. (2007) Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes. Diabetologia 50, 1819-1825
13. Liu, H. R., Tao, L., Gao, E., Qu, Y., Lau, W. B., Lopez, B. L., Christopher, T. A., Koch, W., Yue, T. L. and Ma, X. L. (2009) Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation-a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc. Res. 81, 344-352
14. Kraus, L. M. and Kraus, A. P Jr. (2001) Carbamylation of amino acids and proteins in uremia. Kidney Int. Suppl. 78, S102-S107
15. Apostolov, E. O., Basnakian, A. G., Ok, E. and Shah, S. V. (2012) Carbamylated low-density lipoprotein: non-traditional risk factor for cardiovascular events in patients with chronic kidney disease. J. Renal Nutr. 22, 134-138
16. Apostolov, E. O., Shah, S. V., Ok, E. and Basnakian, A. G. (2007) Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler. Thromb. Vasc. Biol. 27, 826-832
17. Asci, G., Basci, A., Shah, S. V., Basnakian, A., Toz, H., Ozkahya, M., Duman, S. and Ok, E. (2008) Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology 13, 480-486
18. Apostolov, E. O., Shah, S. V., Ray, D. and Basnakian, A. G. (2009) Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler. Thromb. Vasc. Biol. 29, 1622-1630
19. Ok, E., Basnakian, A. G., Apostolov, E. O., Barri, Y. M. and Shah, S. V. (2005) Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 68, 173-178
20. Carracedo, J., Merino, A., Briceno, C., Soriano, S., Buendia, P., Calleros, L., Rodriguez, M., Martin-Malo, A., Aljama, P. and Ramirez, R. (2011) Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J. 25, 1314-1322
21. Sirpal, S. (2009) Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin. Sci. 116, 681-695
22. Podrez, E. A., Abu-Soud, H. M. and Hazen, S. L. (2000) Myeloperoxidase generated oxidants and atherosclerosis. Free Radical Biol. Med. 28, 1717-1725
23. Kumar, A. P., Piedrafita, F. J. and Reynolds, W. F. (2004) Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J. Biol. Chem. 279, 8300-8315
24. Holzer, M., Gauster, M., Pfeifer, T., Wadsack, C., Fauler, G., Stiegler, P., Koefeler, H., Beubler, E., Schuligoi, R., Heinemann, A. and Marsche, G. (2011) Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid. Redox Signaling 14, 2377-2346